Literature DB >> 27183643

Age-Related Decline in Natural IgM Function: Diversification and Selection of the B-1a Cell Pool with Age.

Nichol E Holodick1, Teresa Vizconde2, Thomas J Hopkins2, Thomas L Rothstein3.   

Abstract

Streptococcus pneumoniae is the most common cause of pneumonia, which claims the lives of people over the age of 65 y seven times more frequently than those aged 5-49 y. B-1a cells provide immediate and essential protection from S. pneumoniae through production of natural Ig, which has minimal insertion of N-region additions added by the enzyme TdT. In experiments with SCID mice infected with S. pneumoniae, we found passive transfer of IgG-depleted serum from aged (18-24 mo old) mice had no effect whereas IgG-depleted serum from young (3 mo old) mice was protective. This suggests protective natural IgM changes with age. Using single cell PCR we found N-region addition, which is initially low in fetal-derived B-1a cell IgM developing in the absence of TdT, increased in 7- to 24-mo-old mice as compared with 3-mo-old mice. To determine the mechanism responsible for the age related change in B-1a cell IgM, we established a mixed chimera system in which mice were reconstituted with allotype-marked mature peritoneal B-1a cells and adult bone marrow cells. We demonstrated even in the presence of mature peritoneal B-1a cells, adult bone marrow contributed to the mature B-1a cell pool. More importantly, using this system we found over a 10-mo-period peritoneal B-1a cell IgM changed, showing the number of cells lacking N-region additions at both junctions fell from 49 to 29% of sequences. These results strongly suggest selection-induced skewing alters B-1a cell-derived natural Ab, which may in turn be responsible for the loss of natural IgM-mediated protection against pneumococcal infection.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27183643      PMCID: PMC4874569          DOI: 10.4049/jimmunol.1600073

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  57 in total

1.  National Hospital Discharge Survey: 2007 summary.

Authors:  Margaret Jean Hall; Carol J DeFrances; Sonja N Williams; Aleksandr Golosinskiy; Alexander Schwartzman
Journal:  Natl Health Stat Report       Date:  2010-10-26

Review 2.  The importance of natural IgM: scavenger, protector and regulator.

Authors:  Michael R Ehrenstein; Clare A Notley
Journal:  Nat Rev Immunol       Date:  2010-10-15       Impact factor: 53.106

3.  Impact of the pneumococcal vaccine on long-term morbidity and mortality of adults at high risk for pneumonia.

Authors:  Jennie Johnstone; Dean T Eurich; Jasjeet K Minhas; Thomas J Marrie; Sumit R Majumdar
Journal:  Clin Infect Dis       Date:  2010-07-01       Impact factor: 9.079

4.  IL-7-dependent B lymphocytes are essential for the anti-polysaccharide response and protective immunity to Streptococcus pneumoniae.

Authors:  Anne K Shriner; Hongqi Liu; Guizhi Sun; Martin Guimond; Kishore R Alugupalli
Journal:  J Immunol       Date:  2010-05-26       Impact factor: 5.422

5.  An unbiased analysis of V(H)-D-J(H) sequences from B-1a, B-1b, and conventional B cells.

Authors:  A B Kantor; C E Merrill; L A Herzenberg; J L Hillson
Journal:  J Immunol       Date:  1997-02-01       Impact factor: 5.422

6.  The effect of age on the response to the pneumococcal polysaccharide vaccine.

Authors:  Hyunju Lee; Moon H Nahm; Kyung-Hyo Kim
Journal:  BMC Infect Dis       Date:  2010-03-10       Impact factor: 3.090

7.  Adult BM generates CD5+ B1 cells containing abundant N-region additions.

Authors:  Nichol E Holodick; Karen Repetny; Xuemei Zhong; Thomas L Rothstein
Journal:  Eur J Immunol       Date:  2009-09       Impact factor: 5.532

8.  Induction of B-cell development in adult mice reveals the ability of bone marrow to produce B-1a cells.

Authors:  Sandra Düber; Martin Hafner; Martina Krey; Stefan Lienenklaus; Bishnudeo Roy; Elias Hobeika; Michael Reth; Thorsten Buch; Ari Waisman; Karsten Kretschmer; Siegfried Weiss
Journal:  Blood       Date:  2009-10-07       Impact factor: 22.113

Review 9.  Immune therapy for age-related diseases.

Authors:  Marc E Weksler; Graham Pawelec; Claudio Franceschi
Journal:  Trends Immunol       Date:  2009-06-21       Impact factor: 16.687

10.  A differentiation pathway for B1 cells in adult bone marrow.

Authors:  Brandt L Esplin; Robert S Welner; Qingzhao Zhang; Lisa A Borghesi; Paul W Kincade
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-23       Impact factor: 11.205

View more
  28 in total

Review 1.  Therapeutic Potential of B-1a Cells in COVID-19.

Authors:  Monowar Aziz; Max Brenner; Ping Wang
Journal:  Shock       Date:  2020-11       Impact factor: 3.454

Review 2.  Inflammatory immune cells may impair the preBCR checkpoint, reduce new B cell production, and alter the antibody repertoire in old age.

Authors:  Richard L Riley; Kelly Khomtchouk; Bonnie B Blomberg
Journal:  Exp Gerontol       Date:  2018-02-07       Impact factor: 4.032

3.  Relationship of Autoantibodies to MDA-LDL and ApoB-Immune Complexes to Sex, Ethnicity, Subclinical Atherosclerosis, and Cardiovascular Events.

Authors:  Anand Prasad; Paul Clopton; Colby Ayers; Amit Khera; James A de Lemos; Joseph L Witztum; Sotirios Tsimikas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-05-04       Impact factor: 8.311

Review 4.  A Hard(y) Look at B-1 Cell Development and Function.

Authors:  Nicole Baumgarth
Journal:  J Immunol       Date:  2017-11-15       Impact factor: 5.422

5.  2019 Russell Ross Memorial Lecture in Vascular Biology: B Lymphocyte-Mediated Protective Immunity in Atherosclerosis.

Authors:  Aditi Upadhye; Jeffrey M Sturek; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-12-19       Impact factor: 8.311

6.  Antigen Receptor Specificity and Cell Location Influence the Diversification and Selection of the B-1a Cell Pool with Age.

Authors:  Naomi Tsuji; Thomas L Rothstein; Nichol E Holodick
Journal:  J Immunol       Date:  2020-06-19       Impact factor: 5.422

7.  Therapeutic Potential of B-1a Cells in Intestinal Ischemia-Reperfusion Injury.

Authors:  William Royster; Mahendar Ochani; Monowar Aziz; Ping Wang
Journal:  J Surg Res       Date:  2021-08-13       Impact factor: 2.192

8.  Diversification and CXCR4-Dependent Establishment of the Bone Marrow B-1a Cell Pool Governs Atheroprotective IgM Production Linked to Human Coronary Atherosclerosis.

Authors:  Aditi Upadhye; Prasad Srikakulapu; Ayelet Gonen; Sabrina Hendrikx; Heather M Perry; Anh Nguyen; Chantel McSkimming; Melissa A Marshall; James C Garmey; Angela M Taylor; Timothy P Bender; Sotirios Tsimikas; Nichol E Holodick; Thomas L Rothstein; Joseph L Witztum; Coleen A McNamara
Journal:  Circ Res       Date:  2019-09-24       Impact factor: 17.367

9.  Massively Parallel Sequencing of Peritoneal and Splenic B Cell Repertoires Highlights Unique Properties of B-1 Cell Antibodies.

Authors:  Thomas A Prohaska; Xuchu Que; Cody J Diehl; Sabrina Hendrikx; Max W Chang; Kristen Jepsen; Christopher K Glass; Christopher Benner; Joseph L Witztum
Journal:  J Immunol       Date:  2018-01-29       Impact factor: 5.422

Review 10.  Drivers and regulators of humoral innate immune responses to infection and cancer.

Authors:  Deepak Kumar; Yeni Romero; Kaitlynn N Schuck; Haley Smalley; Bibek Subedi; Sherry D Fleming
Journal:  Mol Immunol       Date:  2020-03-18       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.